United States
-
Athira Pharma to Present Preclinical Data at the American Society for Experimental Neurotherapeutics (ASENT) Annual Meeting
Oral presentation on neurotrophic and procognitive properties of the active metabolite of fosgonimeton in preclinical models First presentation of preclinical data from ATH-1020 candidate for neuropsychiatric conditions BOTHELL, Wash., Feb. 22, 2022 (GLOBE NEWSWIRE) —…
Read More »